XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Net Loss Per Share
9 Months Ended
Dec. 31, 2018
Earnings Per Share [Abstract]  
Net Loss Per Share
Net Loss Per Share
Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, less shares subject to repurchase, and excludes any dilutive effects of employee share-based awards and warrants. Diluted net loss per share is computed giving effect to all potential dilutive common shares, including common stock issuable upon exercise of stock options and unvested restricted common stock. As the Company had net losses for each of the three and nine months ended December 31, 2018 and 2017, all potential common shares were determined to be anti-dilutive, resulting in basic and diluted net loss per share being equal. Additionally, the 4.5 million shares underlying the conversion option in the Notes are not considered in the calculation of diluted net loss per share as the effect would be anti-dilutive. The Notes are not convertible as of December 31, 2018. The Company expects to settle the principal amount of the Notes in cash and therefore use the treasury stock method for calculating any potential dilutive effect of the conversion spread on diluted net income per share, if applicable.
The following table sets forth the computation of net loss per share, basic and diluted (in thousands, except per share amounts):
 
Three Months Ended December 31,
Nine Months Ended December 31,
 
2018
 
2017
2018
 
2017
Numerator:
 
 
 
 
 
 
Net loss attributable to New Relic
$
(10,103
)
 
$
(7,729
)
$
(24,054
)
 
$
(38,354
)
Denominator:
 
 
 
 
 
 
Weighted average shares used to compute net loss per share, basic and diluted
57,096

 
55,196

56,663

 
54,534

Net loss attributable to New Relic per share—basic and diluted
$
(0.18
)
 
$
(0.14
)
$
(0.42
)
 
$
(0.70
)

The following outstanding options, unvested shares, and ESPP shares were excluded (as common stock equivalents) from the computation of diluted net loss per common share for the periods presented as their effect would have been antidilutive (in thousands):
 
As of December 31,
2018
 
2017
Options to purchase common stock
2,874

 
3,450

Restricted stock units
1,891

 
2,038

ESPP shares
62

 
99

 
4,827

 
5,587